Compare AFLAC Incorporated (AFL) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AFLAC Incorporated vs Ginkgo Bioworks Holdings Inc — how do they compare? AFLAC Incorporated trades at $121.06 (market cap $60.70B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: AFLAC Incorporated is far larger — about 120× Ginkgo Bioworks Holdings Inc's market cap, and AFLAC Incorporated pays a 2.02% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| AFL | DNA | |
|---|---|---|
Market Cap | $60.70B | $505.73M |
Sector | Financials | Health |
52-Week High | $129.55 | $16.14 |
52-Week Low | $103.55 | $5.48 |
Enterprise Value | $70.65B | $607.68M |
Dividend Yield | 2.02% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
